Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain
- PMID: 8254734
- PMCID: PMC236283
- DOI: 10.1128/JVI.68.1.240-250.1994
Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain
Abstract
The mature human immunodeficiency virus type 1 proteinase (PR; 11 kDa) can cleave all interdomain junctions in the Gag and Gag-Pol polyprotein precursors. To determine the activity of the enzyme in its precursor form, we blocked release of mature PR from a truncated Gag-Pol polyprotein by introducing mutations into the N-terminal Phe-Pro cleavage site of the PR domain. The mutant precursor autoprocessed efficiently upon expression in Escherichia coli. No detectable mature PR was released; however, several PR-related products ranging in size from approximately 14 to 18 kDa accumulated. Products of the same size were generated when mutant precursors were digested with wild-type PR. Thus, PR can utilize cleavage sites in the region upstream of the PR domain, resulting in the formation of extended PR species. On the basis of active-site titration, the PR species generated from mutated precursor exhibited wild-type activity on peptide substrates. However, the proteolytic activity of these extended enzymes on polyprotein substrates provided exogenously was low when equimolar amounts of extended and wild-type PR proteins were compared. Mammalian cells expressing the mutated precursor produced predominantly precursor and considerably reduced amounts of mature products. Released particles consisted mostly of uncleaved or partially cleaved polyproteins. Our results suggest that precursor forms of PR can autoprocess but are less efficient in processing of the Gag precursor for formation of mature virus particles.
Similar articles
-
Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.J Virol. 1990 Aug;64(8):3938-47. doi: 10.1128/JVI.64.8.3938-3947.1990. J Virol. 1990. PMID: 2196384 Free PMC article.
-
Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1.J Gen Virol. 2001 Mar;82(Pt 3):581-590. doi: 10.1099/0022-1317-82-3-581. J Gen Virol. 2001. PMID: 11172099
-
Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity.J Virol. 1998 Apr;72(4):3459-63. doi: 10.1128/JVI.72.4.3459-3463.1998. J Virol. 1998. PMID: 9525682 Free PMC article.
-
Proteolytic processing of foamy virus Gag and Pol proteins.Curr Top Microbiol Immunol. 2003;277:63-88. doi: 10.1007/978-3-642-55701-9_3. Curr Top Microbiol Immunol. 2003. PMID: 12908768 Review.
-
Beyond Inhibition: A Novel Strategy of Targeting HIV-1 Protease to Eliminate Viral Reservoirs.Viruses. 2022 May 28;14(6):1179. doi: 10.3390/v14061179. Viruses. 2022. PMID: 35746649 Free PMC article. Review.
Cited by
-
Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.J Virol. 2006 Aug;80(16):7832-43. doi: 10.1128/JVI.00374-06. J Virol. 2006. PMID: 16873240 Free PMC article.
-
HIV-1 protease inhibits its homologous reverse transcriptase by protein-protein interaction.Nucleic Acids Res. 1997 May 1;25(9):1709-14. doi: 10.1093/nar/25.9.1709. Nucleic Acids Res. 1997. PMID: 9108151 Free PMC article.
-
Autoprocessing: an essential step for the activation of HIV-1 protease.Biochem J. 1996 Jun 1;316 ( Pt 2)(Pt 2):569-73. doi: 10.1042/bj3160569. Biochem J. 1996. PMID: 8687402 Free PMC article.
-
Ty1 proteolytic cleavage sites are required for transposition: all sites are not created equal.J Virol. 2001 Jan;75(2):638-44. doi: 10.1128/JVI.75.2.638-644.2001. J Virol. 2001. PMID: 11134277 Free PMC article.
-
Human immunodeficiency virus type 1 protease regulation of tat activity is essential for efficient reverse transcription and replication.J Virol. 2003 Sep;77(18):9912-21. doi: 10.1128/jvi.77.18.9912-9921.2003. J Virol. 2003. PMID: 12941901 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials